Search - tctmd.com

Displaying 41 - 60 of 184

Sort: Relevancy | Date

Presentation ACC 2022

Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy

Presenter: Milind Y Desai

April 03, 2022

News Conference News ACC 2022

Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM

Yael L. Maxwell

April 02, 2022

News Conference News ACC 2022

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Shelley Wood

March 28, 2022

Presentation TCT 2021

TCT 611: Look Before You Leap: Cardioplegia Mapping for Alcohol Septal Ablation

Presenter: Nicole Dexter

November 05, 2021

Presentation TCT 2021

TCT 574: Simultaneous Transcatheter Aortic and Mitral Valves Replacements With Alcohol Septal Ablation

Presenter: Matthew Saybolt

November 04, 2021

Presentation TCT 2021

TCT 713: A Case Of Septal Reduction With Tru-Septal RF Ablation Via Coronary Sinus (TIRA) In HOCM Patient: Representative Case of The First in Man Trial Of TIRA

Presenter: Min-Ku Chon

November 04, 2021

News Conference News ACC 2021

‘Enormous’ QoL Improvements With Mavacamten in HCM

Shelley Wood

May 15, 2021

Presentation TCT 2020

TCT 502: Preemptive Alcohol Septal Ablation Prior to Valve-in-Valve Transcatheter Mitral Valve Replacement With Bioprosthetic Balloon Fracture

Presenter: Pedro Engel Gonzalez

October 14, 2020

Presentation TCT 2020

TCT 440: The Impact of Myocardial Fibrosis on Alcohol Septal Ablation Success

Presenter: Amber Makani

October 14, 2020

News Conference News ESC 2020

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

Michael O'Riordan

August 29, 2020

News Daily News

Good Outcomes With Transcatheter Mitral Valve-in-Valve, With Caveats

Todd Neale

July 31, 2020

News Industry News

NuVera Announces Successful First-in-Human Use of NuVision™ ICE Catheter

July 27, 2020

News Daily News

Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns

Shelley Wood

April 13, 2020

Presentation TCT 2019

LVOTO Solution I: Alcohol Septal Ablation

Presenter: Dee Dee Wang

September 28, 2019

Presentation TCT 2019

Long-term Outcomes of Alcohol Septal Ablation

Presenter: George Hanzel

September 28, 2019

Presentation TCT 2019

Alcohol Septal Ablation Complications and Management

Presenter: Hubert Seggewiss

September 28, 2019

Presentation TCT 2019

The Alcohol Septal Ablation Procedure

Presenter: Valerian Fernandes

September 28, 2019

Presentation TCT 2019

Case Selection for Alcohol Septal Ablation

Presenter: Srihari Naidu

September 28, 2019

Presentation TCT 2019

Clinical Presentation, Pathophysiology, and Natural History

Presenter: Bernard Gersh

September 28, 2019

Presentation TCT 2019

Risk Stratification for Sudden Cardiac Death and ICD Implantation

Presenter: Bernard Gersh

September 28, 2019

Advertisement

Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy

Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM

What’s Going to Be Hot at ACC 2022, In Person or Virtual

TCT 611: Look Before You Leap: Cardioplegia Mapping for Alcohol Septal Ablation

TCT 574: Simultaneous Transcatheter Aortic and Mitral Valves Replacements With Alcohol Septal Ablation

TCT 713: A Case Of Septal Reduction With Tru-Septal RF Ablation Via Coronary Sinus (TIRA) In HOCM Patient: Representative Case of The First in Man Trial Of TIRA

‘Enormous’ QoL Improvements With Mavacamten in HCM

TCT 502: Preemptive Alcohol Septal Ablation Prior to Valve-in-Valve Transcatheter Mitral Valve Replacement With Bioprosthetic Balloon Fracture

TCT 440: The Impact of Myocardial Fibrosis on Alcohol Septal Ablation Success

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

Good Outcomes With Transcatheter Mitral Valve-in-Valve, With Caveats

NuVera Announces Successful First-in-Human Use of NuVision™ ICE Catheter

Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns

LVOTO Solution I: Alcohol Septal Ablation

Long-term Outcomes of Alcohol Septal Ablation

Alcohol Septal Ablation Complications and Management

The Alcohol Septal Ablation Procedure

Case Selection for Alcohol Septal Ablation

Clinical Presentation, Pathophysiology, and Natural History

Risk Stratification for Sudden Cardiac Death and ICD Implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content